Symbols / WGRX $0.17 +1.77%
WGRX Chart
About
Wellgistics Health, Inc. engages in the wholesale and distribution of pharmaceutical products to pharmaceutical manufacturers and independent retail pharmacies in the United States. The company distributes generic and branded pharmaceuticals, as well as over-the-counter healthcare and consumer products. It also offers third-party logistics services that include warehousing, inventory management, pick and pack, and shipping to small and mid-size pharmaceutical manufacturers. It also operates DelivMeds platform that serves as a pharmaceutical hub to facilitate the transfer of prescriptions and provide backend clinical concierge services to a network of independent pharmacies; and operates a retail community specialty. The company was formerly known as Danam Health, Inc. and changed its name to Wellgistics Health, Inc. in October 2024. Wellgistics Health, Inc. was incorporated in 2022 and is based in Tampa, Florida.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Pharmaceutical Retailers | Market Cap | 16.98M |
| Enterprise Value | 38.43M | Income | -77.75M | Sales | 34.08M |
| Book/sh | 0.08 | Cash/sh | 0.04 | Dividend Yield | — |
| Payout | 0.00% | Employees | — | IPO | — |
| P/E | — | Forward P/E | — | PEG | — |
| P/S | 0.50 | P/B | 2.16 | P/C | — |
| EV/EBITDA | -0.56 | EV/Sales | 1.13 | Quick Ratio | 0.16 |
| Current Ratio | 0.39 | Debt/Eq | 383.20 | LT Debt/Eq | — |
| EPS (ttm) | -1.28 | EPS next Y | — | EPS Growth | — |
| Revenue Growth | -46.90% | Earnings | — | ROA | -83.23% |
| ROE | -9.28% | ROIC | — | Gross Margin | 7.86% |
| Oper. Margin | -10.47% | Profit Margin | -228.16% | Shs Outstand | 102.12M |
| Shs Float | 39.13M | Short Float | 3.14% | Short Ratio | 1.58 |
| Short Interest | — | 52W High | 7.04 | 52W Low | 0.15 |
| Beta | — | Avg Volume | 2.08M | Volume | 3.09M |
| Target Price | — | Recom | None | Prev Close | $0.16 |
| Price | $0.17 | Change | 1.77% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
$0.15
Latest analyst target
3. DCF / Fair value
$2.12
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.15
Low
—
High
—
Mean
—
- Wellgistics Health Inc. (WGRX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade Sat, 14 Mar 2026 00
- This drug distributor plans to treat patients through an online pharmacy - Stock Titan Fri, 13 Mar 2026 13
- WGRX Earning Date, Earning Analysis and Earning Prediction - Intellectia AI Fri, 13 Mar 2026 10
- Health tech firm Wellgistics moves into $3B insurance check market - Stock Titan Wed, 11 Mar 2026 12
- Could Blockchain Integration Signal a New Competitive Edge for Wellgistics Health (WGRX)? - Yahoo Finance Sun, 26 Oct 2025 07
- Wellgistics President Releases Letter to Shareholder on Emerging Patient Care-Centric Strategic Direction - ChartMill Fri, 13 Mar 2026 13
- Why Wellgistics Health (WGRX) Is Up 139.6% After AI and Blockchain Prescription Tracking Deal Announcement - simplywall.st Sun, 26 Oct 2025 07
- Wellgistics Health stock tumbles after pricing public offering - Investing.com Fri, 26 Sep 2025 07
- Wellgistics stock’s 200% rally on blockchain update is more hype than substance - TradingView Fri, 24 Oct 2025 07
- Wellgistics Secures Preferred Pricing to Advance EBV Platform - TipRanks hu, 12 Mar 2026 00
- $4.9T healthcare system meets blockchain in Wellgistics drug-tracking project - Stock Titan hu, 05 Mar 2026 08
- Datavault AI (DVLT), Wellgistics Health Expand Partnership to Launch Blockchain-Powered HaaS Model - Yahoo Finance Wed, 25 Feb 2026 08
- Reassessing Wellgistics Health (WGRX) Valuation After Blockchain Collaboration Sparks Investor Interest - simplywall.st Mon, 27 Oct 2025 07
- Wellgistics Health Signs Court-Approved Settlement Agreement With Silverback Capital - TradingView Fri, 13 Feb 2026 08
- Ozempic users face muscle loss; Forzet medical food targets it - Stock Titan Mon, 09 Mar 2026 11
Insider Transactions
| Date | Shares | Value | Url | Text | Insider | Position | Transaction | Start Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|
| 0 | 200000 | 180000 | — | Stock Award(Grant) at price 0.90 per share. | PETERSON MICHAEL L | Director | — | 2025-07-02 00:00:00 | D |
| 1 | 200000 | — | — | Stock Award(Grant) at price 0.00 per share. | SHANAHAN REBECCA M | Director | — | 2025-03-21 00:00:00 | D |
| 2 | 200000 | — | — | Stock Award(Grant) at price 0.00 per share. | SYED SAJID | Director | — | 2025-03-21 00:00:00 | D |
| 3 | 4082247 | — | — | Stock Award(Grant) at price 0.00 per share. | PATEL PRASHANT | Officer and Director | — | 2025-03-21 00:00:00 | D/I |
| 4 | 4082247 | — | — | Stock Award(Grant) at price 0.00 per share. | AJJARAPU SURENDRA K | Director | — | 2025-03-21 00:00:00 | D/I |
| 5 | 200000 | — | — | Stock Award(Grant) at price 0.00 per share. | ANDERSON DONALD WILLIAM | Director | — | 2025-03-21 00:00:00 | D |
| 6 | 35000 | — | — | Stock Award(Grant) at price 0.00 per share. | PIRANI SHAFAAT | Officer | — | 2025-03-21 00:00:00 | D |
| 7 | 9000000 | — | — | Stock Award(Grant) at price 0.00 per share. | NORTON BRIAN | Chief Executive Officer | — | 2025-03-21 00:00:00 | D |
| 8 | 90000 | — | — | Stock Award(Grant) at price 0.00 per share. | PANCHAL NIKUL | Officer | — | 2025-03-21 00:00:00 | I |
Financials
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|
| TaxEffectOfUnusualItems | 0.00 | 0.00 | 0.00 |
| TaxRateForCalcs | 0.00 | 0.00 | 0.00 |
| NormalizedEBITDA | -4.91M | -2.88M | -2.19M |
| TotalUnusualItems | 1.82M | ||
| TotalUnusualItemsExcludingGoodwill | 1.82M | ||
| NetIncomeFromContinuingOperationNetMinorityInterest | -6.86M | -2.90M | -2.74M |
| ReconciledDepreciation | 1.11M | 0.00 | 2.09M |
| ReconciledCostOfRevenue | 16.36M | 0.00 | 27.03M |
| EBITDA | -4.91M | -2.88M | -369.03K |
| EBIT | -6.02M | -2.88M | -2.46M |
| NetInterestIncome | -831.47K | -15.08K | -287.18K |
| InterestExpense | 831.47K | 15.08K | 287.18K |
| NormalizedIncome | -6.86M | -2.90M | -4.56M |
| NetIncomeFromContinuingAndDiscontinuedOperation | -6.86M | -2.90M | -2.74M |
| TotalExpenses | 24.27M | 2.88M | 36.20M |
| TotalOperatingIncomeAsReported | -6.15M | -2.88M | -3.42M |
| DilutedAverageShares | 47.25M | 44.72M | 47.25M |
| BasicAverageShares | 47.25M | 44.72M | 47.25M |
| DilutedEPS | -0.15 | -0.06 | -0.06 |
| BasicEPS | -0.15 | -0.06 | -0.06 |
| DilutedNIAvailtoComStockholders | -6.86M | -2.90M | -2.74M |
| NetIncomeCommonStockholders | -6.86M | -2.90M | -2.74M |
| NetIncome | -6.86M | -2.90M | -2.74M |
| NetIncomeIncludingNoncontrollingInterests | -6.86M | -2.90M | -2.74M |
| NetIncomeContinuousOperations | -6.86M | -2.90M | -2.74M |
| TaxProvision | 0.00 | 0.00 | 0.00 |
| PretaxIncome | -6.86M | -2.90M | -2.74M |
| OtherIncomeExpense | 120.37K | 98.13K | 966.11K |
| OtherNonOperatingIncomeExpenses | 120.37K | 180.46K | -851.94K |
| SpecialIncomeCharges | 1.82M | ||
| OtherSpecialCharges | -1.82M | ||
| EarningsFromEquityInterest | -82.33K | ||
| NetNonOperatingInterestIncomeExpense | -831.47K | -15.08K | -287.18K |
| InterestExpenseNonOperating | 831.47K | 15.08K | 287.18K |
| OperatingIncome | -6.15M | -2.88M | -3.42M |
| OperatingExpense | 7.91M | 2.88M | 9.17M |
| DepreciationAmortizationDepletionIncomeStatement | 1.11M | 0.00 | 2.09M |
| DepreciationAndAmortizationInIncomeStatement | 1.11M | 0.00 | 2.09M |
| ResearchAndDevelopment | 375.00 | 1.40K | |
| SellingGeneralAndAdministration | 6.80M | 2.88M | 7.08M |
| GeneralAndAdministrativeExpense | 6.80M | 2.88M | 7.08M |
| OtherGandA | 6.80M | 2.88M | 7.08M |
| GrossProfit | 1.77M | 0.00 | 5.75M |
| CostOfRevenue | 16.36M | 0.00 | 27.03M |
| TotalRevenue | 18.13M | 0.00 | 32.78M |
| OperatingRevenue | 18.13M | 0.00 | 32.78M |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|
| OrdinarySharesNumber | 51.94M | 51.94M | 51.94M |
| ShareIssued | 51.94M | 51.94M | 51.94M |
| NetDebt | 22.46M | 348.64K | |
| TotalDebt | 25.11M | 350.00K | |
| TangibleBookValue | -31.85M | -2.90M | -5.25K |
| InvestedCapital | 30.23M | -2.55M | -5.25K |
| WorkingCapital | -22.88M | -2.55M | -5.25K |
| NetTangibleAssets | -31.85M | -2.90M | -5.25K |
| CapitalLeaseObligations | 1.62M | 0.00 | |
| CommonStockEquity | 6.73M | -2.90M | -5.25K |
| TotalCapitalization | 18.19M | -2.55M | -5.25K |
| TotalEquityGrossMinorityInterest | 6.73M | -2.90M | -5.25K |
| StockholdersEquity | 6.73M | -2.90M | -5.25K |
| RetainedEarnings | -9.76M | -2.90M | -5.25K |
| AdditionalPaidInCapital | 16.49M | -3.97K | |
| CapitalStock | 5.11K | 4.47K | 0.00 |
| CommonStock | 5.11K | 4.47K | 0.00 |
| TotalLiabilitiesNetMinorityInterest | 50.60M | 3.24M | 5.25K |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 12.55M | 350.00K | 0.00 |
| LongTermDebtAndCapitalLeaseObligation | 12.55M | 350.00K | |
| LongTermCapitalLeaseObligation | 1.10M | 0.00 | |
| LongTermDebt | 11.46M | 350.00K | |
| CurrentLiabilities | 38.05M | 2.89M | 5.25K |
| CurrentDeferredLiabilities | 245.76K | 0.00 | |
| CurrentDeferredRevenue | 245.76K | 0.00 | |
| CurrentDebtAndCapitalLeaseObligation | 12.56M | 350.00K | |
| CurrentCapitalLeaseObligation | 519.49K | 0.00 | |
| CurrentDebt | 12.04M | 350.00K | |
| OtherCurrentBorrowings | 11.93M | 250.00K | |
| LineOfCredit | 110.20K | 0.00 | |
| CurrentNotesPayable | 100.00K | 0.00 | |
| PensionandOtherPostRetirementBenefitPlansCurrent | 3.11M | 1.30M | 0.00 |
| PayablesAndAccruedExpenses | 22.13M | 1.59M | 5.25K |
| CurrentAccruedExpenses | 851.98K | 482.33K | 0.00 |
| InterestPayable | 504.15K | 2.33K | 0.00 |
| Payables | 21.28M | 1.11M | 5.25K |
| OtherPayable | 10.00M | ||
| DuetoRelatedPartiesCurrent | 4.94M | 67.79K | 0.00 |
| AccountsPayable | 6.33M | 1.04M | 5.25K |
| TotalAssets | 57.33M | 338.36K | 0.00 |
| TotalNonCurrentAssets | 42.16M | 0.00 | 0.00 |
| OtherNonCurrentAssets | 1.42M | ||
| NonCurrentPrepaidAssets | 85.01K | 0.00 | |
| NonCurrentNoteReceivables | 139.77K | 0.00 | |
| InvestmentsAndAdvances | 17.67K | 0.00 | |
| LongTermEquityInvestment | 17.67K | 0.00 | |
| GoodwillAndOtherIntangibleAssets | 38.58M | 0.00 | |
| OtherIntangibleAssets | 22.36M | ||
| Goodwill | 16.22M | 0.00 | |
| NetPPE | 1.92M | 0.00 | |
| AccumulatedDepreciation | -1.12M | 0.00 | |
| GrossPPE | 3.04M | 0.00 | |
| Leases | 766.47K | 0.00 | |
| OtherProperties | 2.12M | ||
| MachineryFurnitureEquipment | 152.16K | 0.00 | |
| Properties | 0.00 | 0.00 | |
| CurrentAssets | 15.17M | 338.36K | 0.00 |
| OtherCurrentAssets | 1.00 | ||
| CurrentDeferredAssets | 875.38K | 0.00 | |
| PrepaidAssets | 524.00 | 0.00 | |
| Inventory | 9.52M | 0.00 | |
| InventoriesAdjustmentsAllowances | -233.60K | 0.00 | |
| OtherInventories | 6.72M | ||
| FinishedGoods | 3.03M | 0.00 | |
| Receivables | 3.75M | 337.00K | 0.00 |
| DuefromRelatedPartiesCurrent | 1.02M | 337.00K | 0.00 |
| AccountsReceivable | 2.72M | 0.00 | |
| AllowanceForDoubtfulAccountsReceivable | -940.60K | 0.00 | |
| GrossAccountsReceivable | 3.67M | 0.00 | |
| CashCashEquivalentsAndShortTermInvestments | 1.03M | 1.36K | 0.00 |
| CashAndCashEquivalents | 1.03M | 1.36K | 0.00 |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|
| FreeCashFlow | -1.60M | -349.14K | 0.00 |
| RepaymentOfDebt | -135.78K | 0.00 | |
| IssuanceOfDebt | 756.48K | 350.00K | 0.00 |
| IssuanceOfCapitalStock | 10.00K | 500.00 | 0.00 |
| CapitalExpenditure | -377.29K | ||
| EndCashPosition | 1.03M | 1.36K | 0.00 |
| BeginningCashPosition | 1.36K | 0.00 | 0.00 |
| ChangesInCash | 1.03M | 1.36K | |
| FinancingCashFlow | 1.78M | 350.50K | 0.00 |
| CashFlowFromContinuingFinancingActivities | 1.78M | 350.50K | 0.00 |
| NetOtherFinancingCharges | 1.15M | ||
| NetCommonStockIssuance | 10.00K | 500.00 | 0.00 |
| CommonStockIssuance | 10.00K | 500.00 | 0.00 |
| NetIssuancePaymentsOfDebt | 620.70K | 350.00K | 0.00 |
| NetShortTermDebtIssuance | 620.70K | 0.00 | 0.00 |
| ShortTermDebtPayments | -135.78K | 0.00 | |
| ShortTermDebtIssuance | 756.48K | 0.00 | 0.00 |
| NetLongTermDebtIssuance | 0.00 | 350.00K | |
| LongTermDebtIssuance | 0.00 | 350.00K | |
| InvestingCashFlow | 469.07K | 0.00 | |
| CashFlowFromContinuingInvestingActivities | 469.07K | 0.00 | |
| NetOtherInvestingChanges | -85.01K | ||
| NetBusinessPurchaseAndSale | 931.37K | 0.00 | |
| SaleOfBusiness | 931.37K | 0.00 | |
| NetIntangiblesPurchaseAndSale | -377.29K | 0.00 | |
| PurchaseOfIntangibles | -377.29K | 0.00 | |
| OperatingCashFlow | -1.22M | -349.14K | 0.00 |
| CashFlowFromContinuingOperatingActivities | -1.22M | -349.14K | 0.00 |
| ChangeInWorkingCapital | 3.34M | 2.55M | 5.25K |
| ChangeInOtherWorkingCapital | 3.33M | -269.21K | |
| ChangeInOtherCurrentLiabilities | 22.09K | 0.00 | |
| ChangeInOtherCurrentAssets | -587.54K | 0.00 | |
| ChangeInPayablesAndAccruedExpense | 682.26K | 2.82M | 5.25K |
| ChangeInAccruedExpense | 1.56M | 1.78M | 0.00 |
| ChangeInPayable | -882.32K | 1.03M | 5.25K |
| ChangeInAccountPayable | -882.32K | 1.03M | 5.25K |
| ChangeInPrepaidAssets | 11.44K | 0.00 | |
| ChangeInInventory | -72.36K | 0.00 | |
| ChangeInReceivables | -40.08K | 0.00 | |
| ChangesInAccountReceivables | -40.08K | 0.00 | |
| StockBasedCompensation | 1.08M | 0.00 | |
| AssetImpairmentCharge | 93.38K | 0.00 | |
| DepreciationAmortizationDepletion | 1.11M | 0.00 | |
| DepreciationAndAmortization | 1.11M | 0.00 | |
| AmortizationCashFlow | 1.05M | 0.00 | |
| AmortizationOfIntangibles | 1.05M | 0.00 | |
| Depreciation | 67.62K | 0.00 | |
| NetIncomeFromContinuingOperations | -6.86M | -2.90M | -5.25K |
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
Public Trades for WGRX
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|